Search

everythinglearnresearchcommunity

for

Search:↓

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

Dogs with epilepsy have different hair mineral levels than healthy dogs, possibly due to epilepsy or its treatment.

Non-drug therapies show promise for hair regrowth but need more research.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Weight loss can cause temporary hair loss, especially in women and older adults.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Alopecia Areata might be linked to Crohn's disease.